Immunology

Making immunotherapy safe for AML

Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...

Oncology & Cancer

Study reveals colon tumor location matters for metastatic disease

Colon cancers that spread to the liver may be substantially different depending on the location where cancerous cells originate, according to new research. The study led by Yale Cancer Center researchers at Yale School of ...

page 3 from 40